238 related articles for article (PubMed ID: 12076195)
1. Enoxaparin: an update of its clinical use in the management of acute coronary syndromes.
Ibbotson T; Goa KL
Drugs; 2002; 62(9):1407-30. PubMed ID: 12076195
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin. A review of its clinical potential in the management of coronary artery disease.
Noble S; Spencer CM
Drugs; 1998 Aug; 56(2):259-72. PubMed ID: 9711450
[TBL] [Abstract][Full Text] [Related]
3. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B.
Turpie AG
Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029
[TBL] [Abstract][Full Text] [Related]
4. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
Cohen M
Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
[TBL] [Abstract][Full Text] [Related]
5. TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.
Antman EM
Am Heart J; 1998 Jun; 135(6 Pt 3 Su):S353-60. PubMed ID: 9628449
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
[TBL] [Abstract][Full Text] [Related]
7. Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies.
Bijsterveld NR; Peters RJ; Murphy SA; Bernink PJ; Tijssen JG; Cohen M
J Am Coll Cardiol; 2003 Dec; 42(12):2083-9. PubMed ID: 14680731
[TBL] [Abstract][Full Text] [Related]
8. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
Fox KA; Antman EM; Cohen M; Bigonzi F;
Am J Cardiol; 2002 Sep; 90(5):477-82. PubMed ID: 12208405
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
Antman EM; McCabe CH; Gurfinkel EP; Turpie AG; Bernink PJ; Salein D; Bayes De Luna A; Fox K; Lablanche JM; Radley D; Premmereur J; Braunwald E
Circulation; 1999 Oct; 100(15):1593-601. PubMed ID: 10517729
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trial.
Goodman S
Am Heart J; 2005 Apr; 149(4 Suppl):S73-80. PubMed ID: 16124951
[TBL] [Abstract][Full Text] [Related]
11. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
Cohen M; Théroux P; Borzak S; Frey MJ; White HD; Van Mieghem W; Senatore F; Lis J; Mukherjee R; Harris K; Bigonzi F;
Am Heart J; 2002 Sep; 144(3):470-7. PubMed ID: 12228784
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective.
Balen RM; Marra CA; Zed PJ; Cohen M; Frighetto L
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):533-42. PubMed ID: 10662478
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B.
Fox KA
Semin Hematol; 2001 Apr; 38(2 Suppl 5):67-74. PubMed ID: 11449345
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of anticoagulation in acute coronary syndromes.
Latour-Pérez J; de-Miguel-Balsa E
Pharmacoeconomics; 2012 Apr; 30(4):303-21. PubMed ID: 22409291
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups.
Cohen M; Antman EM; Gurfinkel EP; Radley D;
J Thromb Thrombolysis; 2001 Dec; 12(3):199-206. PubMed ID: 11981102
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II).
Ross AM; Molhoek P; Lundergan C; Knudtson M; Draoui Y; Regalado L; Le Louer V; Bigonzi F; Schwartz W; de Jong E; Coyne K;
Circulation; 2001 Aug; 104(6):648-52. PubMed ID: 11489769
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials.
Collet JP; Montalescot G; Fine E; Golmard JL; Dalby M; Choussat R; Ankri A; Dumaine R; Lesty C; Vignolles N; Thomas D
J Am Coll Cardiol; 2003 Jan; 41(1):8-14. PubMed ID: 12570937
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
Antman EM; Louwerenburg HW; Baars HF; Wesdorp JC; Hamer B; Bassand JP; Bigonzi F; Pisapia G; Gibson CM; Heidbuchel H; Braunwald E; Van de Werf F
Circulation; 2002 Apr; 105(14):1642-9. PubMed ID: 11940541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
